Cargando…

Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy

Detalles Bibliográficos
Autores principales: Dal Collo, Giada, Takam Kamga, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526481/
https://www.ncbi.nlm.nih.gov/pubmed/37760473
http://dx.doi.org/10.3390/cancers15184503
_version_ 1785111032472010752
author Dal Collo, Giada
Takam Kamga, Paul
author_facet Dal Collo, Giada
Takam Kamga, Paul
author_sort Dal Collo, Giada
collection PubMed
description
format Online
Article
Text
id pubmed-10526481
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105264812023-09-28 Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy Dal Collo, Giada Takam Kamga, Paul Cancers (Basel) Editorial MDPI 2023-09-10 /pmc/articles/PMC10526481/ /pubmed/37760473 http://dx.doi.org/10.3390/cancers15184503 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Dal Collo, Giada
Takam Kamga, Paul
Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
title Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
title_full Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
title_fullStr Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
title_full_unstemmed Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
title_short Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
title_sort unlocking the potential of biomarkers for immune checkpoint inhibitors in cancer therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526481/
https://www.ncbi.nlm.nih.gov/pubmed/37760473
http://dx.doi.org/10.3390/cancers15184503
work_keys_str_mv AT dalcollogiada unlockingthepotentialofbiomarkersforimmunecheckpointinhibitorsincancertherapy
AT takamkamgapaul unlockingthepotentialofbiomarkersforimmunecheckpointinhibitorsincancertherapy